Illinois 100th Regular Session Status: Passed House 1 D cosponsors

HB 274 — PHARMACY-BIRTH CONTROL

Last action — Session Sine Die

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 100th Regular Session. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Amends the Pharmacy Practice Act. Provides that "practice of pharmacy" includes the prescribing and dispensing of hormonal contraceptive patches and self-administered oral hormonal contraceptives. Defines "hormonal contraceptive patch" as a transdermal patch applied to the skin of a patient, by the patient or by a practitioner, that releases a drug composed of a combination of hormones that is approved by the United States Food and Drug Administration to prevent pregnancy and "self-administered oral hormonal contraceptive" as a drug composed of a combination of hormones that is approved by the United States Food and Drug Administration to prevent pregnancy and that the patient to whom the drug is prescribed may take orally. Allows pharmacists to prescribe and dispense contraceptives to a person over 18 years of age and a person under 18 years of age only if the person has evidence of a previous prescription from a primary care or a women's health care practitioner. Requires the Department of Financial and Professional Regulation to adopt rules to establish standard procedures for pharmacists to prescribe contraceptives. Provides requirements for the rules to be adopted by the Department. Provides that all State and federal laws governing insurance coverage of contraceptive drugs and products shall apply to the provisions.

Bill Text

What changed in the latest version

580 added · 436 removed

Plain-language change summary

The recent changes to Bill HB 274 primarily focus on updating the health benefits provisions related to post-mastectomy care and insurance compliance under the Illinois Insurance Code. This amendment now requires that health benefit programs include comprehensive coverage for various health conditions and treatments that align with state insurance regulations. These updates are crucial as they ensure that individuals receiving post-mastectomy care have access to necessary services without facing undue financial burdens, ultimately improving patient outcomes and support during recovery.

→
Previous
Latest
*LRB10004385SMS14391b* HB0274 100TH GENERAL ASSEMBLY State of Illinois and 2018 HB0274 by Rep.
HB0274 Engrossed LRB100 04385 SMS 14391 b AN ACT concerning regulation.
Michelle Mussman SYNOPSIS AS INTRODUCED:
ILCS 85/3 ILCS 85/19.7 new Amends the Pharmacy Practice Act.
Provides that "practice of pharmacy" includes the prescribing and dispensing of hormonal contraceptive patches and self-administered oral hormonal contraceptives.
Defines "hormonal contraceptive patch" as a transdermal patch applied to the skin of a patient, by the patient or by a practitioner, that releases a drug composed of a combination of hormones that is approved by the United States Food and Drug Administration to prevent pregnancy and "self-administered oral hormonal contraceptive" as a drug composed of a combination of hormones that is approved by the United States Food and Drug Administration to prevent pregnancy and that the patient to whom the drug is prescribed may take orally.
Allows pharmacists to prescribe and dispense contraceptives to a person over 18 years of age and a person under 18 years of age only if the person has evidence of a previous prescription from a primary care or a women's health care practitioner.
Requires the Department of Financial and Professional Regulation to adopt rules to establish standard procedures for pharmacists to prescribe contraceptives.
Provides requirements for the rules to be adopted by the Department.
Provides that all State and federal laws governing insurance coverage of contraceptive drugs and products shall apply to the provisions.
LRB100 04385 SMS 14391 b FISCAL NOTE ACT MAY APPLY A BILL FOR HB0274 LRB100 04385 SMS 14391 b AN ACT concerning regulation.
The Pharmacy Practice Act is amended by changing Section 3 and by adding Section 19.7 as follows:
The State Employees Group Insurance Act of 1971 is amended by changing Section 6.11 as follows:
(225 ILCS 85/3) (Section scheduled to be repealed on January 1, 2018) Sec.
(5 ILCS 375/6.11) Sec.
6.11.
Required health benefits;
Illinois Insurance Code requirements.
The program of health benefits shall provide the post-mastectomy care benefits required to be covered by a policy of accident and health insurance under Section 356t of the Illinois Insurance Code.
The program of health benefits shall provide the coverage required under Sections 356g, 356g.5, 356g.5-1, 356m, 356u, 356w, 356x, 356z.2, 356z.4, 356z.6, 356z.8, 356z.9, 356z.10, 356z.11, 356z.12, 356z.13, 356z.14, 356z.15, 356z.17, 356z.22, and 356z.25, 356z.26, and 356z.29 of the Illinois Insurance Code.
The program of health benefits must comply with Sections 155.22a, 155.37, 355b, 356z.19, 370c, and 370c.1 of the Illinois Insurance Code.
Rulemaking authority to implement Public Act 95-1045, if any, is conditioned on the rules being adopted in accordance with all provisions of the Illinois Administrative Procedure Act and all rules and procedures of the Joint Committee on Administrative Rules;
any purported rule not so adopted, for HB0274 Engrossed - 2 - LRB100 04385 SMS 14391 b whatever reason, is unauthorized.
(Source:
P.A.
99-480, eff.
9-9-15;
100-24, eff.
7-18-17;
100-138, eff.
8-18-17;
revised 10-3-17.) Section 10.
The Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois is amended by adding Section 2310-700 as follows:
(20 ILCS 2310/2310-700 new) Sec.
2310-700.
Contraceptive drugs and products;
Director standing order.
(a) As used in this Section:
"Hormonal contraceptive" means a prescribed medically-acceptable oral drug, transdermal patch, or vaginal ring that is approved by the United States Food and Drug Administration to prevent pregnancy.
"Standing order" has the meaning given to that term in the Pharmacy Practice Act.
(b) If the Director of Public Health is a physician licensed to practice medicine in all its branches in Illinois, the Director shall establish a standing order complete with the issuance of a prescription for a hormonal contraceptive in accordance with this Section.
If the Director is not a physician licensed to practice medicine in all its branches in Illinois, then the Medical Director of the Department of Public Health shall establish a standing order in accordance with this HB0274 Engrossed - 3 - LRB100 04385 SMS 14391 b Section.
(c) The standing order, at a minimum, shall comply with the following:
Show all 180 changed rows (140 more)
Previous
Latest
(1) A pharmacist may dispense a 12-month supply of hormonal contraceptives to a patient.
(2) A pharmacist shall have the patient complete the self-screening risk assessment tool.
The self-screening risk assessment tool is to be based on the most current version of the United States Medical Eligibility Criteria for Contraceptive Use published by the federal Centers for Disease Control and Prevention.
(3) Based upon the results of the self-screening risk assessment and the patient assessment, the pharmacist shall use his or her professional and clinical judgment as to when a patient should be referred to the patient's physician or another health care provider.
(4) The pharmacist shall provide, during the patient assessment and consultation, counseling and education about all methods of contraception, including methods not covered under the standing order, and their proper use and effectiveness.
(5) The patient consultation shall take place in a private manner consistent with rules adopted by the Department of Financial and Professional Regulation.
(6) The Department shall adopt rules under this Section that require a pharmacist to:
HB0274 Engrossed - 4 - LRB100 04385 SMS 14391 b (A) complete an educational training program accredited by the Accreditation Council for Pharmacy Education and approved by the Department that is related to the patient self-screening risk assessment, patient assessment, contraceptive counseling and education, and dispensation of hormonal contraceptives;
and (B) dispense the hormonal contraceptive to the patient as soon as practicable after meeting the requirements of paragraph (2).
(7) All State and federal laws governing insurance coverage of contraceptive drugs shall apply to hormonal contraceptives dispensed by a pharmacist under this Section.
Section 15.
The Counties Code is amended by changing Section 5-1069.3 as follows:
(55 ILCS 5/5-1069.3) Sec.
5-1069.3.
Required health benefits.
If a county, including a home rule county, is a self-insurer for purposes of providing health insurance coverage for its employees, the coverage shall include coverage for the post-mastectomy care benefits required to be covered by a policy of accident and health insurance under Section 356t and the coverage required under Sections 356g, 356g.5, 356g.5-1, 356u, 356w, 356x, HB0274 Engrossed - 5 - LRB100 04385 SMS 14391 b 356z.6, 356z.8, 356z.9, 356z.10, 356z.11, 356z.12, 356z.13, 356z.14, 356z.15, 356z.22, and 356z.25, 356z.26, and 356z.29 of the Illinois Insurance Code.
The coverage shall comply with Sections 155.22a, 355b, 356z.19, and 370c of the Illinois Insurance Code.
The requirement that health benefits be covered as provided in this Section is an exclusive power and function of the State and is a denial and limitation under Article VII, Section 6, subsection (h) of the Illinois Constitution.
A home rule county to which this Section applies must comply with every provision of this Section.
Rulemaking authority to implement Public Act 95-1045, if any, is conditioned on the rules being adopted in accordance with all provisions of the Illinois Administrative Procedure Act and all rules and procedures of the Joint Committee on Administrative Rules;
any purported rule not so adopted, for whatever reason, is unauthorized.
(Source:
P.A.
99-480, eff.
9-9-15;
100-24, eff.
7-18-17;
100-138, eff.
8-18-17;
revised 10-5-17.) Section 20.
The Illinois Municipal Code is amended by changing Section 10-4-2.3 as follows:
(65 ILCS 5/10-4-2.3) Sec.
10-4-2.3.
Required health benefits.
If a municipality, including a home rule municipality, is a self-insurer for purposes of providing health insurance HB0274 Engrossed - 6 - LRB100 04385 SMS 14391 b coverage for its employees, the coverage shall include coverage for the post-mastectomy care benefits required to be covered by a policy of accident and health insurance under Section 356t and the coverage required under Sections 356g, 356g.5, 356g.5-1, 356u, 356w, 356x, 356z.6, 356z.8, 356z.9, 356z.10, 356z.11, 356z.12, 356z.13, 356z.14, 356z.15, 356z.22, and 356z.25, 356z.26, and 356z.29 of the Illinois Insurance Code.
The coverage shall comply with Sections 155.22a, 355b, 356z.19, and 370c of the Illinois Insurance Code.
The requirement that health benefits be covered as provided in this is an exclusive power and function of the State and is a denial and limitation under Article VII, Section 6, subsection (h) of the Illinois Constitution.
A home rule municipality to which this Section applies must comply with every provision of this Section.
Rulemaking authority to implement Public Act 95-1045, if any, is conditioned on the rules being adopted in accordance with all provisions of the Illinois Administrative Procedure Act and all rules and procedures of the Joint Committee on Administrative Rules;
any purported rule not so adopted, for whatever reason, is unauthorized.
(Source:
P.A.
99-480, eff.
9-9-15;
100-24, eff.
7-18-17;
100-138, eff.
8-18-17;
revised 10-5-17.) Section 25.
The School Code is amended by changing Section 10-22.3f as follows:
HB0274 Engrossed - 7 - LRB100 04385 SMS 14391 b (105 ILCS 5/10-22.3f) Sec.
10-22.3f.
Required health benefits.
Insurance protection and benefits for employees shall provide the post-mastectomy care benefits required to be covered by a policy of accident and health insurance under Section 356t and the coverage required under Sections 356g, 356g.5, 356g.5-1, 356u, 356w, 356x, 356z.6, 356z.8, 356z.9, 356z.11, 356z.12, 356z.13, 356z.14, 356z.15, 356z.22, and 356z.25, 356z.26, and 356z.29 of the Illinois Insurance Code.
Insurance policies shall comply with Section 356z.19 of the Illinois Insurance Code.
The coverage shall comply with Sections 155.22a and 355b of the Illinois Insurance Code.
Rulemaking authority to implement Public Act 95-1045, if any, is conditioned on the rules being adopted in accordance with all provisions of the Illinois Administrative Procedure Act and all rules and procedures of the Joint Committee on Administrative Rules;
any purported rule not so adopted, for whatever reason, is unauthorized.
(Source:
P.A.
100-24, eff.
7-18-17;
100-138, eff.
8-18-17;
revised 9-25-17.) Section 30.
The Illinois Insurance Code is amended by adding Section 356z.29 as follows:
(215 ILCS 5/356z.29 new) Sec.
356z.29.
Coverage for patient care services for HB0274 Engrossed - 8 - LRB100 04385 SMS 14391 b hormonal contraceptives provided by a pharmacist.
A group or individual policy of accident and health insurance or a managed care plan that is amended, delivered, issued, or renewed after the effective date of this amendatory Act of the 100th General Assembly shall provide coverage for patient care services provided by a pharmacist for hormonal contraceptives assessment and consultation.
Section 35.
The Pharmacy Practice Act is amended by changing Section 3 as follows:
(225 ILCS 85/3) (Section scheduled to be repealed on January 1, 2020) Sec.
or (2) where prescriptions of physicians, dentists, advanced practice nurses, physician assistants, veterinarians, podiatric physicians, or optometrists, within the limits of their licenses, are compounded, filled, or dispensed;
or (2) where prescriptions of physicians, dentists, advanced practice registered nurses, physician assistants, veterinarians, podiatric physicians, or optometrists, within the limits of their licenses, are compounded, filled, or dispensed;
or (3) which has upon it or displayed within it, or affixed to or used in connection with it, a sign bearing the word or words "Pharmacist", "Druggist", "Pharmacy", "Pharmaceutical Care", "Apothecary", "Drugstore", "Medicine Store", "Prescriptions", "Drugs", "Dispensary", "Medicines", or any word or words of HB0274 - 2 - LRB100 04385 SMS 14391 b similar or like import, either in the English language or any other language;
or (3) which has upon it or displayed within it, or affixed to or used in connection with it, a sign bearing the word or words HB0274 Engrossed - 9 - LRB100 04385 SMS 14391 b "Pharmacist", "Druggist", "Pharmacy", "Pharmaceutical Care", "Apothecary", "Drugstore", "Medicine Store", "Prescriptions", "Drugs", "Dispensary", "Medicines", or any word or words of similar or like import, either in the English language or any other language;
(c) "Medicines" means and includes all drugs intended for human or veterinary use approved by the United States Food and Drug Administration.
HB0274 Engrossed - 10 - LRB100 04385 SMS 14391 b (c) "Medicines" means and includes all drugs intended for human or veterinary use approved by the United States Food and Drug Administration.
HB0274 - 3 - LRB100 04385 SMS 14391 b (d) "Practice of pharmacy" means (1) the interpretation and the provision of assistance in the monitoring, evaluation, and implementation of prescription drug orders;
(d) "Practice of pharmacy" means:
(1) the interpretation and the provision of assistance in the monitoring, evaluation, and implementation of prescription drug orders;
in the context of patient education on the proper use or delivery of medications;
(A) in the context of patient education on the proper use or delivery of medications;
vaccination of patients 14 years of age and older pursuant to a valid prescription or standing order, by a physician licensed to practice medicine in all its branches, upon completion of appropriate training, including how to address contraindications and adverse reactions set forth by rule, with notification to the patient's physician and appropriate record retention, or pursuant to hospital pharmacy and therapeutics committee policies and procedures;
(B) vaccination of patients 14 years of age and older pursuant to a valid prescription or standing order, by a physician licensed to practice medicine in all its branches, upon completion of appropriate training, including how to address contraindications and adverse reactions set forth by rule, with notification to the patient's physician and appropriate record retention, or pursuant to hospital pharmacy and therapeutics committee policies and procedures;
and (C) administration of injections of alpha-hydroxyprogesterone caproate, pursuant to a valid prescription, by a physician licensed to HB0274 Engrossed - 11 - LRB100 04385 SMS 14391 b practice medicine in all its branches, upon completion of appropriate training, including how to address contraindications and adverse reactions set forth by rule, with notification to the patient's physician and appropriate record retention, or pursuant to hospital pharmacy and therapeutics committee policies and procedures;
(7) HB0274 - 4 - LRB100 04385 SMS 14391 b drug or drug-related research;
(7) drug or drug-related research;
and (12) the responsibility for compounding and labeling of drugs and devices (except labeling by a manufacturer, repackager, or distributor of non-prescription drugs and commercially packaged legend drugs and devices), proper and safe storage of drugs and devices, and maintenance of required records;
and HB0274 Engrossed - 12 - LRB100 04385 SMS 14391 b (12) the responsibility for compounding and labeling of drugs and devices (except labeling by a manufacturer, repackager, or distributor of non-prescription drugs and commercially packaged legend drugs and devices), proper and safe storage of drugs and devices, and maintenance of required records;
and (13) the prescribing and dispensing of hormonal contraceptive patches and self-administered oral hormonal contraceptives.
and.
(13) the assessment and consultation of patients and dispensing of hormonal contraceptives pursuant to the standing order under Section 2310-700 of the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois.
(e) "Prescription" means and includes any written, oral, facsimile, or electronically transmitted order for drugs or medical devices, issued by a physician licensed to practice medicine in all its branches, dentist, veterinarian, podiatric physician, or optometrist, within the limits of their licenses, by a physician assistant in accordance with subsection (f) of Section 4, or by an advanced practice nurse in accordance with subsection (g) of Section 4, containing the following:
(e) "Prescription" means and includes any written, oral, facsimile, or electronically transmitted order for drugs or medical devices, issued by a physician licensed to practice medicine in all its branches, dentist, veterinarian, podiatric physician, or optometrist, within the limits of his or her license their licenses, by a physician assistant in accordance with subsection (f) of Section 4, or by an advanced practice registered nurse in accordance with subsection (g) of Section 4, containing the following:
(6) prescriber's name, address, and signature;
(6) prescriber's name, address, and HB0274 Engrossed - 13 - LRB100 04385 SMS 14391 b signature;
and (7) DEA number HB0274 - 5 - LRB100 04385 SMS 14391 b where required, for controlled substances.
and (7) DEA registration number where required, for controlled substances.
DEA numbers shall not be required on inpatient drug orders.
DEA registration numbers shall not be required on inpatient drug orders.
(f) "Person" means and includes a natural person, copartnership, association, corporation, government entity, or any other legal entity.
(f) "Person" means and includes a natural person, partnership, association, corporation, government entity, or any other legal entity.
(k) "Inpatient drug order" means an order issued by an authorized prescriber for a resident or patient of a facility licensed under the Nursing Home Care Act, the ID/DD Community Care Act, the MC/DD Act, the Specialized Mental Health Rehabilitation Act of 2013, or the Hospital Licensing Act, or "An Act in relation to the founding and operation of the University of Illinois Hospital and the conduct of University of Illinois health care programs", approved July 3, 1931, as HB0274 - 6 - LRB100 04385 SMS 14391 b amended, or a facility which is operated by the Department of Human Services (as successor to the Department of Mental Health and Developmental Disabilities) or the Department of Corrections.
(k) "Inpatient drug order" means an order issued by an authorized prescriber for a resident or patient of a facility licensed under the Nursing Home Care Act, the ID/DD Community Care Act, the MC/DD Act, the Specialized Mental Health Rehabilitation Act of 2013, the Hospital Licensing Act, or the University of Illinois Hospital Act "An Act in relation to the founding and operation of the University of Illinois Hospital HB0274 Engrossed - 14 - LRB100 04385 SMS 14391 b and the conduct of University of Illinois health care programs", approved July 3, 1931, as amended, or a facility which is operated by the Department of Human Services (as successor to the Department of Mental Health and Developmental Disabilities) or the Department of Corrections.
(n) "Nonresident pharmacy" means a pharmacy that is located HB0274 - 7 - LRB100 04385 SMS 14391 b in a state, commonwealth, or territory of the United States, other than Illinois, that delivers, dispenses, or distributes, through the United States Postal Service, commercially acceptable parcel delivery service, or other common carrier, to Illinois residents, any substance which requires a prescription.
HB0274 Engrossed - 15 - LRB100 04385 SMS 14391 b (n) "Nonresident pharmacy" means a pharmacy that is located in a state, commonwealth, or territory of the United States, other than Illinois, that delivers, dispenses, or distributes, through the United States Postal Service, commercially acceptable parcel delivery service, or other common carrier, to Illinois residents, any substance which requires a prescription.
(r) "Patient counseling" means the communication between a pharmacist or a student pharmacist under the supervision of a HB0274 - 8 - LRB100 04385 SMS 14391 b pharmacist and a patient or the patient's representative about the patient's medication or device for the purpose of optimizing proper use of prescription medications or devices.
(r) "Patient counseling" means the communication between a HB0274 Engrossed - 16 - LRB100 04385 SMS 14391 b pharmacist or a student pharmacist under the supervision of a pharmacist and a patient or the patient's representative about the patient's medication or device for the purpose of optimizing proper use of prescription medications or devices.
(u) "Medical device" means an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component part or accessory, required under federal law to bear the label "Caution:
(u) "Medical device" or "device" means an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component part or accessory, required under federal law to bear the label "Caution:
Federal law requires dispensing by or on the order of a physician".
Federal law requires dispensing by or on HB0274 Engrossed - 17 - LRB100 04385 SMS 14391 b the order of a physician".
A seller of goods and services who, only for the HB0274 - 9 - LRB100 04385 SMS 14391 b purpose of retail sales, compounds, sells, rents, or leases medical devices shall not, by reasons thereof, be required to be a licensed pharmacy.
A seller of goods and services who, only for the purpose of retail sales, compounds, sells, rents, or leases medical devices shall not, by reasons thereof, be required to be a licensed pharmacy.
(11) proper utilization (including over or under utilization) HB0274 - 10 - LRB100 04385 SMS 14391 b and optimum therapeutic outcomes;
HB0274 Engrossed - 18 - LRB100 04385 SMS 14391 b (11) proper utilization (including over or under utilization) and optimum therapeutic outcomes;
(z) "Electronic transmission prescription" means any prescription order for which a facsimile or electronic image of the order is electronically transmitted from a licensed prescriber to a pharmacy.
(z) "Electronically transmitted prescription" means a prescription that is created, recorded, or stored by electronic means;
"Electronic transmission prescription" includes both data and image prescriptions.
issued and validated with an electronic signature;
(aa) "Medication therapy management services" means a distinct service or group of services offered by licensed pharmacists, physicians licensed to practice medicine in all its branches, advanced practice nurses authorized in a written agreement with a physician licensed to practice medicine in all its branches, or physician assistants authorized in guidelines by a supervising physician that optimize therapeutic outcomes for individual patients through improved medication use.
and transmitted by electronic means directly from the prescriber to a pharmacy.
An electronic prescription is not an image of a physical prescription that is transferred by electronic means from computer to computer, facsimile to facsimile, or facsimile to computer.
(aa) "Medication therapy management services" means a distinct service or group of services offered by licensed pharmacists, physicians licensed to practice medicine in all its branches, advanced practice registered nurses authorized in a written agreement with a physician licensed to practice medicine in all its branches, or physician assistants authorized in guidelines by a supervising physician that optimize therapeutic outcomes for individual patients through improved medication use.
(3) reasonable dose, duration of use, and route of administration, taking into consideration factors such as age, gender, and contraindications;
(3) reasonable dose, duration of use, and route of administration, taking into consideration factors such as HB0274 Engrossed - 19 - LRB100 04385 SMS 14391 b age, gender, and contraindications;
HB0274 - 11 - LRB100 04385 SMS 14391 b (7) drug-food interactions;
(7) drug-food interactions;
"Medication therapy management services" may also include patient care functions authorized by a physician licensed to practice medicine in all its branches for his or her identified patient or groups of patients under specified conditions or limitations in a standing order from the physician.
"Medication therapy management services" may also include patient care functions authorized by a physician licensed to HB0274 Engrossed - 20 - LRB100 04385 SMS 14391 b practice medicine in all its branches for his or her identified patient or groups of patients under specified conditions or limitations in a standing order from the physician.
"Medication therapy management services" in a licensed HB0274 - 12 - LRB100 04385 SMS 14391 b hospital may also include the following:
"Medication therapy management services" in a licensed hospital may also include the following:
(1) education records covered by the federal Family Educational Right and Privacy Act;
HB0274 Engrossed - 21 - LRB100 04385 SMS 14391 b (1) education records covered by the federal Family Educational Right and Privacy Act;
HB0274 - 13 - LRB100 04385 SMS 14391 b (dd) "Standing order" means a specific order for a patient or group of patients issued by a physician licensed to practice medicine in all its branches in Illinois.
(dd) "Standing order" means a specific order for a patient or group of patients issued by a physician licensed to practice medicine in all its branches in Illinois.
(ee) "Address of record" means the address recorded by the Department in the applicant's or licensee's application file or license file, as maintained by the Department's licensure maintenance unit.
(ee) "Address of record" means the designated address recorded by the Department in the applicant's application file or licensee's license file maintained by the Department's licensure maintenance unit.
(gg) "Email address of record" means the designated email address recorded by the Department in the applicant's application file or the licensee's license file, as maintained by the Department's licensure maintenance unit.
98-104, eff.
7-22-13;
98-214, eff.
8-9-13;
98-756, eff.
7-16-14;
7-29-15.) (225 ILCS 85/19.7 new) Sec.
7-29-15;
19.7.
100-208, eff.
Contraceptive drugs and products.
1-1-18;
(a) As used in this Section:
100-497, eff.
"Hormonal contraceptive patch" means a transdermal patch applied to the skin of a patient, by the patient or by a practitioner, that releases a drug composed of a combination of hormones that is approved by the United States Food and Drug Administration to prevent pregnancy.
9-8-17;
"Self-administered oral hormonal contraceptives" means a drug composed of a combination of hormones that is approved by the United States Food and Drug Administration to prevent pregnancy and that the patient to whom the drug is prescribed may take orally.
100-513, eff.
(b) A pharmacist may prescribe and dispense hormonal HB0274 - 14 - LRB100 04385 SMS 14391 b contraceptive patches and self-administered oral hormonal contraceptives to a person who is:
1-1-18;
(1) at least 18 years of age, regardless of whether the person has evidence of a previous prescription from a primary care practitioner or a women's health care practitioner for a hormonal contraceptive patch or self-administered oral hormonal contraceptive;
revised 9-29-17.) Section 40.
or (2) under 18 years of age only if the person has evidence of a previous prescription from a primary care practitioner or a women's health care practitioner for a hormonal contraceptive patch or self-administered oral hormonal contraceptive.
The Illinois Public Aid Code is amended by adding Section 5-5.12b as follows:
(c) The Department shall adopt rules to establish, in consideration of guidelines established by the American Congress of Obstetricians and Gynecologists, standard procedures for the prescribing of hormonal contraceptive patches and self-administered oral hormonal contraceptives by pharmacists.
(305 ILCS 5/5-5.12b new) Sec.
(d) The rules adopted under this Section must require a pharmacist to:
5-5.12b.
(1) complete a training program approved by the Department that is related to prescribing hormonal contraceptive patches and self-administered oral hormonal contraceptives;
Coverage for patient care services for hormonal contraceptives provided by a pharmacist.
(2) provide a self-screening risk assessment tool that the patient must use prior to the pharmacist's prescribing HB0274 - 15 - LRB100 04385 SMS 14391 b the hormonal contraceptive patch or self-administered oral hormonal contraceptive;
HB0274 Engrossed - 22 - LRB100 04385 SMS 14391 b (a) Subject to approval by the federal Centers for Medicare and Medicaid Services, the medical assistance program, including both the fee-for-service and managed care medical assistance programs established under this Article, shall cover patient care services provided by a pharmacist for hormonal contraceptives assessment and consultation.
(3) refer the patient to the patient's primary care practitioner or women's health care practitioner upon prescribing and dispensing the hormonal contraceptive patch or self-administered oral hormonal contraceptive;
(b) The Department shall establish a fee schedule for patient care services provided by a pharmacist for hormonal contraceptives assessment and consultation.
(4) provide the patient with a written record of the hormonal contraceptive patch or self-administered oral hormonal contraceptive prescribed and dispensed and advise the patient to consult with a primary care practitioner or women's health care practitioner;
(c) The rate of reimbursement for patient care services provided by a pharmacist for hormonal contraceptives assessment and consultation shall be at 85% of the fee schedule for physician services by the medical assistance program.
and (5) dispense the hormonal contraceptive patch or self-administered oral hormonal contraceptive to the patient as soon as practicable after the pharmacist issues the prescription.
(d) A pharmacist must be enrolled in the medical assistance program as an ordering and referring provider prior to providing hormonal contraceptives assessment and consultation that is submitted by a pharmacy or pharmacist provider for reimbursement pursuant to this Section.
(e) The rules adopted under this Section must prohibit a pharmacist from:
(e) The Director shall seek any necessary federal waivers or approvals to implement this Section.
(1) requiring a patient to schedule an appointment with the pharmacist for the prescribing or dispensing of a hormonal contraceptive patch or self-administered oral hormonal contraceptive;
This Section shall not be implemented until the receipt of all necessary federal waivers or approvals or until January 1, 2021, whichever comes first.
and (2) prescribing and dispensing a hormonal contraceptive patch or self-administered oral hormonal contraceptive to a patient who does not have evidence of a clinical visit for women's health within the 3 years immediately following the initial prescription and HB0274 - 16 - LRB100 04385 SMS 14391 b dispensation of a hormonal contraceptive patch or self-administered oral hormonal contraceptive by a pharmacist to the patient.
If federal approval is not obtained by January 1, 2021, the provisions of this Section shall be implemented using State funds.
(f) All State and federal laws governing insurance coverage of contraceptive drugs, devices, products, and services shall apply to hormonal contraceptive patches and self-administered oral hormonal contraceptives prescribed by a pharmacist under this Section.
(f) This Section does not restrict or prohibit any services HB0274 Engrossed - 23 - LRB100 04385 SMS 14391 b currently provided by pharmacists as authorized by law, including, but not limited to, pharmacist services provided under this Code or authorized under the Illinois Title XIX State Plan.
(g) The Department shall adopt administrative rules for this Section as soon as practicable but no later than May 1, 2019.
Section 99.
Effective date.
This Act takes effect January 1, 2019.
View plain text versions (2)

Action History

  1. Session Sine Die

  2. Final Action Deadline Extended-9(b) May 25, 2018

  3. Rule 19(a) / Re-referred to Rules Committee

  4. Third Reading - Consideration Postponed

  5. Placed on Calendar - Consideration Postponed

  6. Placed on Calendar Order of 3rd Reading - Standard Debate

  7. Removed from Short Debate Status

  8. Placed on Calendar Order of 3rd Reading - Short Debate

  9. Fiscal Note Request is Inapplicable

  10. House Committee Amendment No. 1 Motion Prevailed 057-045-000

  11. House Committee Amendment No. 1 Note / Motion Filed - Note Act Does Not Apply Rep. Michelle Mussman

  12. Held on Calendar Order of Second Reading - Short Debate

  13. House Floor Amendment No. 2 Adopted

  14. Second Reading - Short Debate

  15. Added Co-Sponsor Rep. Jonathan Carroll

  16. House Floor Amendment No. 2 Recommends Be Adopted Health Care Licenses Committee; 010-003-000

  17. House Floor Amendment No. 2 Rules Refers to Health Care Licenses Committee

  18. House Floor Amendment No. 2 Referred to Rules Committee

  19. House Floor Amendment No. 2 Filed with Clerk by Rep. Michelle Mussman

  20. House Committee Amendment No. 1 State Mandates Fiscal Note Filed as Amended

  21. House Committee Amendment No. 1 State Mandates Fiscal Note Requested as Amended by Rep. Barbara Wheeler

  22. House Committee Amendment No. 1 Fiscal Note Requested as Amended by Rep. Barbara Wheeler

  23. Placed on Calendar 2nd Reading - Short Debate

  24. Do Pass as Amended / Short Debate Health Care Licenses Committee; 010-006-000

  25. House Committee Amendment No. 1 Adopted in Health Care Licenses Committee; by Voice Vote

  26. Added Co-Sponsor Rep. Katie Stuart

  27. House Committee Amendment No. 1 Rules Refers to Health Care Licenses Committee

  28. Added Co-Sponsor Rep. Carol Sente

  29. Added Co-Sponsor Rep. Kelly M. Cassidy

  30. Added Co-Sponsor Rep. Rita Mayfield

  31. Added Co-Sponsor Rep. Laura Fine

  32. Added Co-Sponsor Rep. Robyn Gabel

  33. Added Co-Sponsor Rep. Sam Yingling

  34. Added Co-Sponsor Rep. Theresa Mah

  35. Added Co-Sponsor Rep. Barbara Flynn Currie

  36. House Committee Amendment No. 1 Referred to Rules Committee

  37. House Committee Amendment No. 1 Filed with Clerk by Rep. Michelle Mussman

  38. Assigned to Health Care Licenses Committee

  39. Added Co-Sponsor Rep. John Connor

  40. Rule 19(a) / Re-referred to Rules Committee

  41. Committee Deadline Extended-Rule 9(b) April 28, 2017

  42. Added Co-Sponsor Rep. Natalie A. Manley

  43. Added Co-Sponsor Rep. Juliana Stratton

  44. Added Co-Sponsor Rep. Sonya M. Harper

  45. Added Co-Sponsor Rep. Emanuel Chris Welch

  46. Added Co-Sponsor Rep. Robert Rita

  47. Added Co-Sponsor Rep. John C. D'Amico

  48. Added Co-Sponsor Rep. Sara Feigenholtz

  49. Added Co-Sponsor Rep. Silvana Tabares

  50. Added Co-Sponsor Rep. Martin J. Moylan

  51. Added Co-Sponsor Rep. Thaddeus Jones

  52. Assigned to Health Care Licenses Committee

  53. Referred to Rules Committee

  54. First Reading

  55. Prefiled with Clerk by Rep. Michelle Mussman

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

0 sponsors · 1 co-sponsors · 182 not signed on · 11 voted No

Sponsors (0)

None.

Co-sponsors (1)

Not signed on (182)

182 members have not signed on to this bill.

Show all 182 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Motion

Failed 57 Yea · 45 Nay · 16 Other
Party YeaNayPresentNot Voting
Unaffiliated 3034010
Republican 01002
Democrat 27104
Total 5745016
% of votes cast 48%38%0%14%
How each member voted (118)
Member Party Vote
Batinick — Nay
Bellock — Nay
Bourne — Not Voting
Breen — Nay
Bristow — Nay
Butler — Nay
Carroll — Yea
McDermed — Nay
Lang — Yea
Harris, Gregory — Yea
Burke, Daniel — Yea
Burke, Kelly — Yea
Sente — Yea
Jones — Yea
Stratton — Yea
Tabares — Yea
Thapedi — Yea
Turner — Yea
Wallace — Yea
Davis — Yea
Williams — Yea
Mitchell, Christian — Yea
Willis — Yea
Yingling — Yea
Zalewski — Yea
Bennett — Nay
Brady — Nay
Harris, David — Nay
Connor — Yea
Conroy — Yea
Conyears-Ervin — Yea
Currie — Yea
D'Amico — Yea
Flowers — Yea
Frese — Nay
Greenwood — Yea
Hays — Nay
Hurley — Yea
Ives — Nay
Long — Nay
Madigan — Not Voting
Wheeler, Keith — Nay
Mitchell, Bill — Nay
McAuliffe — Nay
Finnie, Natalie — Nay
Sauer — Not Voting
Hernandez — Not Voting
Wheeler, Barbara — Not Voting
McSweeney — Nay
Olsen — Nay
Stewart — Nay
Unes — Nay
Wehrli — Nay
Cavaletto — Nay
Costello — Nay
Demmer — Nay
Drury — Not Voting
Durkin — Nay
Fortner — Not Voting
Jimenez — Nay
Welter — Nay
Winger — Nay
Jesiel — Nay
Parkhurst — Nay
Phillips — Not Voting
Pritchard — Nay
Reis — Not Voting
Riley — Yea
Skillicorn — Nay
Sommer — Nay
Soto — Not Voting
Andersson — Yea
Arroyo — Yea
Chapa LaVia — Yea
Anna Moeller Democrat Yea
Anthony DeLuca Democrat Not Voting
Camille Y. Lilly Democrat Yea
Carol Ammons Democrat Yea
Emanuel "Chris" Welch Democrat Yea
Fred Crespo Democrat Yea
Jaime M. Andrade, Jr. Democrat Yea
Jay Hoffman Democrat Yea
Jehan Gordon-Booth Democrat Yea
Julie A. Morrison Democrat Not Voting
Justin Slaughter Democrat Yea
Katie Stuart Democrat Yea
Kelly M. Cassidy Democrat Not Voting
La Shawn K. Ford Democrat Yea
Laura Fine Democrat Yea
Lawrence "Larry" Walsh, Jr. Democrat Yea
Marcus C. Evans, Jr. Democrat Yea
Martin J. Moylan Democrat Yea
Michael W. Halpin Democrat Yea
Michelle Mussman Democrat Yea
Natalie A. Manley Democrat Yea
Nicholas K. Smith Democrat Yea
Rita Mayfield Democrat Yea
Robert "Bob" Rita Democrat Yea
Robert F. Martwick Democrat Yea
Robyn Gabel Democrat Not Voting
Sara Feigenholtz Democrat Yea
Sonya M. Harper Democrat Yea
Stephanie A. Kifowit Democrat Yea
Sue Scherer Democrat Nay
Theresa Mah Democrat Yea
Will Guzzardi Democrat Yea
Brad Halbrook Republican Nay
Charles Meier Republican Nay
Christopher "C.D." Davidsmeyer Republican Nay
Dan Swanson Republican Nay
Dave Severin Republican Nay
Joe C. Sosnowski Republican Not Voting
John M. Cabello Republican Nay
Norine K. Hammond Republican Nay
Ryan Spain Republican Not Voting
Steven Reick Republican Nay
Terri Bryant Republican Nay
Tony M. McCombie Republican Nay

Official roll call →

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 274 do?
Amends the Pharmacy Practice Act. Provides that "practice of pharmacy" includes the prescribing and dispensing of hormonal contraceptive patches and self-administered oral hormonal contraceptives. Defines "hormonal contraceptive patch" as a transdermal patch applied to the skin of a patient, by the patient or by a practitioner, that releases a drug composed of a combination of hormones that is approved by the United States Food and Drug Administration to prevent pregnancy and "self-administered oral hormonal contraceptive" as a drug composed of a combination of hormones that is approved by the United States Food and Drug Administration to prevent pregnancy and that the patient to whom the drug is prescribed may take orally. Allows pharmacists to prescribe and dispense contraceptives to a person over 18 years of age and a person under 18 years of age only if the person has evidence of a previous prescription from a primary care or a women's health care practitioner. Requires the Department of Financial and Professional Regulation to adopt rules to establish standard procedures for pharmacists to prescribe contraceptives. Provides requirements for the rules to be adopted by the Department. Provides that all State and federal laws governing insurance coverage of contraceptive drugs and products shall apply to the provisions.
Who sponsors HB 274?
HB 274 is sponsored by Michelle Mussman (Democrat).
What is the current status of HB 274?
This bill died with 100th Regular Session. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 274?
Track HB 274 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 274

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HB 274

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →